马上注册,结交更多好友,享用更多功能,让你轻松玩转社区。
您需要 登录 才可以下载或查看,没有账号?立即注册
x
http://us.boehringer-ingelheim.c ... of-september-2.html
Ridgefield, CT, August 22, 2013 – Boehringer Ingelheim Pharmaceuticals, Inc. has announced that GilotrifTM (afatinib) tablets for oral use will be commercially available in the U.S. the week of September 2.
The U.S. Food and Drug Administration (FDA) approved GILOTRIF on July 12, 2013 as a new first-line – or initial – treatment for patients with metastatic non-small cell lung cancer (NSCLC) with common epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test. Safety and efficacy of GILOTRIF have not been established in patients whose tumors have other EGFR mutations.
|
|
个人公众号:treeofhope
|
|
共24条精彩回复,最后回复于 2021-5-15 18:32
尚未签到
尚未签到
尚未签到
尚未签到
尚未签到
期待好的消息,顶起 |
|
|
|
尚未签到
尚未签到
上次让朋友打听了一下,一会儿说十几万,一会儿说六、七万一个月,反正用不起啊 |
|
|
|
尚未签到
唠叨的老人 发表于 2013-9-3 14:36
上次让朋友打听了一下,一会儿说十几万,一会儿说六、七万一个月,反正用不起啊
期待国内能早点上市 |
|
|
|
尚未签到
马老师,我小弟吃特7个月,脑转,走路有些不稳了,说话也不利索了。但肺部控制还好,肝部比2个月前见涨。换2992呢,还是299804,还是其他药好呢?请您给出个主意。 |
|
|
|